not achieve their goal of democratizing access to vaccines. In this sense, the current TRIPS (Agreement on Trade … and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the … beginning of vaccination is marked by the deepening of vaccine nationalism, the concentration of inputs and vaccines production …

support national patent offices and interested parties in developing countries with information that can serve as guidance for … the examination of the claims contained in relevant patents or patent applications. The medicines considered for the … patent analysis in this report are remdesivir, ruxolitinib, favipiravir, molnupiravir and nirmatrelvir, and the …

The purpose of this report is to analyze the impact that the COVID-19 pandemic has had on the vaccine industry from an … paradigm of competitive market efficiency with notorious market failures. We examine the impact of the pandemic on innovation … and the scientific, technological and industrial development of vaccines and find that certain elements of the industry …

health. However, there was uncertainty with respect to the interpretation of TRIPS agreement, scope of the flexibilities and …, reconciled the interpretative tensions in the text of TRIPS Agreement and clarified the scope of some of the flexibilities and …The major bone of contention between the developed and developing countries in the TRIPS negotiations was patents for …

), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a … extreme urgency" within the meaning of Article 31(b) of the TRIPS Agreement. Some legislations, such as European competition …